Si-Bone Closes $21M Round of Financing

SI BONESi-Bone, Inc., a San Jose, California-based medical device company, closed a $21m round of growth capital financing.

The round was led by new investor Redline Capital Management with participation from all existing major investors.

The company intends to use the funds for further expansion in the U.S. and Europe and enter into the Middle East, Asia and South America.

Led by Jeffrey Dunn, President and CEO, Si-Bone is manufacturing the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint.



Join the discussion